Omnicell (NASDAQ: OMCL) and Greenway Health (NYSE:GWAY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership.

Insider and Institutional Ownership

99.6% of Omnicell shares are held by institutional investors. 3.8% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Omnicell and Greenway Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Omnicell -0.51% -0.79% -0.38%
Greenway Health N/A N/A N/A

Earnings & Valuation

This table compares Omnicell and Greenway Health’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Omnicell $692.62 million 2.76 $600,000.00 ($0.11) -458.18
Greenway Health N/A N/A N/A ($0.17) N/A

Omnicell has higher revenue and earnings than Greenway Health. Omnicell is trading at a lower price-to-earnings ratio than Greenway Health, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Omnicell and Greenway Health, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omnicell 0 1 6 0 2.86
Greenway Health 0 0 0 0 N/A

Omnicell presently has a consensus target price of $55.14, indicating a potential upside of 9.41%.

Summary

Omnicell beats Greenway Health on 5 of the 8 factors compared between the two stocks.

About Omnicell

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

About Greenway Health

Greenway Health LLC is a United States-based company, which provides clinical, financial and administrative solutions for healthcare providers. The Company provides integrated clinically driven revenue cycle management and electronic health record (EHR) solutions. Its suite of solutions and services is PrimeSUITE, which integrates clinical, financial and administrative data in a single database to enable views of patient records and workflow throughout each patient encounter, reduce clinical and administrative errors, and allow for the exchange of data between its customers and the healthcare community. It offers its solutions by offering managed business services, such as clinically-driven revenue cycle and EHR-enabled research services.

Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.